Target intelligence / Profile preview

Probable ATP-dependent RNA helicase DDX17 (DDX17)

Target
DDX17
Molecular classification
Enzyme (RNA helicase), Chromatin regulator/transcriptional cofactor, RNA-binding protein, Other (DEAD box protein family)
01

Overview

Probable ATP-dependent RNA helicase DDX17 is a multifunctional RNA helicase belonging to the DEAD-box protein family, characterized by the conserved Asp-Glu-Ala-Asp motif. DDX17 regulates a variety of key cellular processes, including RNA secondary structure modification, pre-mRNA alternative splicing, ribosome and spliceosome assembly, microRNA processing, and acts as a transcriptional coactivator or corepressor, participating in chromatin remodeling and influencing chromatin accessibility. Its roles extend to cell differentiation, embryogenesis, and spermatogenesis. DDX17 is also implicated in disease processes such as cancer, where it may act as an oncogene or tumor suppressor, and in cardiovascular disease, where its expression correlates with protection against heart failure via support of mitochondrial homeostasis. DDX17 closely interacts with other helicases such as DDX5 and with chromatin modifiers (e.g., HDAC1, CBP/p300). The broad involvement and essential functions of DDX17 categorize it as a fundamental gene and protein for RNA metabolism and gene regulation, but currently, no therapeutics directly targeting DDX17 are in clinical use.

Other names
DEAD-box helicase 17DDX17p72DEAD box protein 17DEAD box protein p72DEAD box protein p82RNA-dependent helicase p72p72 RNA helicaseRH70DEAD (Asp-Glu-Ala-Asp) box helicase 17DEAD box polypeptide 17DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 17 (72kD)
02

Mechanism of action

Not established for drugs, but as a target, modulation of ATP-dependent RNA unwinding, alteration of spliceosome function, or regulation of chromatin state are conceivable therapeutic mechanisms

03

Biological functions

RNA secondary structure alterationAlternative splicing of pre-mRNARibosome and spliceosome assemblyTranscription coactivation and corepressionRegulation of microRNA processingNuclear and mitochondrial RNA splicingCellular growth and divisionChromatin remodelingEmbryogenesis, spermatogenesisCell differentiationRegulation of mitochondrial homeostasis in the heart
04

Disease associations

Cancer (including oncogenic and possible tumor suppressor functions)Cardiovascular disease (heart failure, cardiac injury)Infection (e.g., Rift Valley Fever)Developmental disorder (Treacher Collins Syndrome 1)
05

Safety considerations

Non-specific modulation could impact fundamental processes such as global gene expression, RNA splicing, chromatin structure, ribosome biogenesis, and cell divisionPossible oncogenic or tumor suppressor effects complicate therapeutic targetingEssential role in heart function suggests risk for cardiac side effects
06

Biomarkers

DDX17 expression may be a biomarker in: Cancer (deregulation documented in tumors)DDX17 expression may be a biomarker in: Cardiac injury and heart failure (downregulation seen in models)No patient selection or efficacy biomarkers established in clinical use from results.

Beyond the preview

Go deeper on Probable ATP-dependent RNA helicase DDX17 (DDX17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probable ATP-dependent RNA helicase DDX17 (DDX17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call